These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 24811412

  • 1. Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
    Heneghan CJ, Onakpoya I, Thompson M, Spencer EA, Jones M, Jefferson T.
    BMJ; 2014 Apr 09; 348():g2547. PubMed ID: 24811412
    [Abstract] [Full Text] [Related]

  • 2. Neuraminidase inhibitors for preventing and treating influenza in adults and children.
    Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ.
    Cochrane Database Syst Rev; 2014 Apr 10; 2014(4):CD008965. PubMed ID: 24718923
    [Abstract] [Full Text] [Related]

  • 3. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
    Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ.
    BMJ; 2014 Apr 09; 348():g2545. PubMed ID: 24811411
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
    Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.
    Cochrane Database Syst Rev; 2012 Apr 18; 2012(4):CD002744. PubMed ID: 22513907
    [Abstract] [Full Text] [Related]

  • 7. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.
    Cochrane Database Syst Rev; 2012 Jan 18; 1():CD002744. PubMed ID: 22258949
    [Abstract] [Full Text] [Related]

  • 8. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.
    Shun-Shin M, Thompson M, Heneghan C, Perera R, Harnden A, Mant D.
    BMJ; 2009 Aug 10; 339():b3172. PubMed ID: 19666987
    [Abstract] [Full Text] [Related]

  • 9. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A.
    Cochrane Database Syst Rev; 2003 Aug 10; (3):CD002744. PubMed ID: 12917931
    [Abstract] [Full Text] [Related]

  • 10. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ, Harnden AR, Perera R, Sheikh A, Symmonds-Abrahams M.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD002744. PubMed ID: 17253479
    [Abstract] [Full Text] [Related]

  • 11. Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.
    Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K.
    Health Technol Assess; 2009 Feb 24; 13(11):iii, ix-xii, 1-246. PubMed ID: 19215705
    [Abstract] [Full Text] [Related]

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 13. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb 01; 15(81):21-30. PubMed ID: 16548114
    [Abstract] [Full Text] [Related]

  • 14. Spotlight on zanamivir in influenza.
    Cheer SM, Wagstaff AJ.
    Am J Respir Med; 2002 Feb 01; 1(2):147-52. PubMed ID: 14720068
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Antiviral Agents for Seasonal Influenza Outcomes in Healthy Adults and Children: A Systematic Review and Network Meta-analysis.
    Liu JW, Lin SH, Wang LC, Chiu HY, Lee JA.
    JAMA Netw Open; 2021 Aug 02; 4(8):e2119151. PubMed ID: 34387680
    [Abstract] [Full Text] [Related]

  • 16. Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.
    Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton NJ, Ades AE, Sutton A, Cooper N, Elliot AJ, Nicholson K, Duffy S, McKenna C, Stewart L, Westwood M, Palmer S.
    Health Technol Assess; 2009 Nov 02; 13(58):1-265, iii-iv. PubMed ID: 19954682
    [Abstract] [Full Text] [Related]

  • 17. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
    Jefferson T, Jones M, Doshi P, Del Mar C.
    BMJ; 2009 Dec 08; 339():b5106. PubMed ID: 19995812
    [Abstract] [Full Text] [Related]

  • 18. Zanamivir: an update of its use in influenza.
    Cheer SM, Wagstaff AJ.
    Drugs; 2002 Dec 08; 62(1):71-106. PubMed ID: 11790157
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
    Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG.
    BMJ; 2003 Jun 07; 326(7401):1235. PubMed ID: 12791735
    [Abstract] [Full Text] [Related]

  • 20. Effect of zanamivir on duration and resolution of influenza symptoms.
    Monto AS, Moult AB, Sharp SJ.
    Clin Ther; 2000 Nov 07; 22(11):1294-305. PubMed ID: 11117654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.